Press Release

Morgan Lewis Tops BioPharm Insight Second-Quarter League Tables

September 16, 2014

PHILADELPHIA, September 16, 2014: Morgan Lewis is pleased to announce that its Life Sciences and Healthcare practice has again placed among the top firms in BioPharm Insight’s quarterly league tables. In the 2014 second-quarter league tables, Morgan Lewis ranked first among Legal Advisors on Biotech and Pharma Licensing Agreements, based on both value and volume.

BioPharm Insight is a market provider of up-to-date information and coverage of global drug licensing deals as they take place. It publishes quarterly league tables to rank licensing activity in the life sciences industry, based on pharmaceutical drug licensing agreements announced during the period. In addition to Morgan Lewis’s top ranking in the latest tables, the firm has received the following rankings from BioPharm Insight in the last 12 months:

  • 2nd – Global: Legal Advisers to Biotech and Pharma Licensing Agreements – Based upon Value – ($4,103M)
  • 2nd – North America: Legal Advisors to Biotech and Pharma Licensing Agreements – Based upon Value – ($3,935M)
  • 4th – Europe: Legal Advisors to Biotech and Pharma Licensing Agreements – Based upon Value – (2,273M)
  • 2nd – Asia-Pacific: Legal Advisors to Biotech and Pharma Licensing Agreements – Based upon Volume (4 deals)